• Info
    • INFORMATION
    • Documentation
    • Tutorial
      • General introduction
      • Tutorial
      • Workshop materials
      • Workshop manual (PDF)
      • Workshop manual (Word)
      • Workshop videos
    • FOR DEVELOPERS
    • Linking to GPCRdb
    • Web services
  • GPCRdb
    • Citing GPCRdb
    • Receptor page
    • Data Mapper
    • SEQUENCES
    • Sequence alignments
    • Generic residue number tables
    • Generic variants
    • Isoforms
    • SEQUENCE ANALYSIS
    • Receptor similarity
      • BLAST (GPCRdb alignment)
      • BLAST (non-GPCRdb query)
      • Phylogenetic trees
      • Similarity matrix (all-to-all)
    • Site search (by seq. motif)
    • STRUCTURES
    • Structure coverage
    • Structures
    • Structure models (receptor)
    • Structure models (ligand complexes)
    • STRUCTURE ANALYSIS
    • Structure comparison tool
    • Structure similarity trees
    • Structure superposition
    • Generic residue numbering (PDB)    
    • Structure similarity search
    • STRUCTURE CONSTRUCTS
    • Construct/Experiment design
      • Construct alignments
      • Construct design tool
      • Experiment browser
    • Truncation/Fusion analysis
      • Truncation sites
      • Fusion sites
      • Loop deletions
    • Mutation analysis
      • Stabilising mutations
      • StabMutAnalyser
      • Mutation substitution matrix
    • DETERMINANTS & MUTATIONS
    • Sequence signature tool
    • State stabilizing mutation design
  • Drugs & ligands
    • LIGANDS & BIOACTIVITIES
    • Ligand coverage
    • Ligands (ChEMBL, GtP, Ki db)
      • Ligands (by receptor query)
      • Ligands (by ligand query)
    • PHYSIOLOGICAL LIGANDS
    • Physiological ligands (GtP)
    • DRUGS & AGENTS IN TRIAL
    • Agents/drugs
      • Agent/drug page
      • Agents/drugs by phase I-IV
    • Targets
      • Target page
      • Targets by phase I-IV
      • The drugged GPCRome
      • Target selection tool
    • Diseases
      • Disease page
      • Disease overview
    • LIGAND SITES
    • GPCR-ligand interactions
    • Site search
      • Site search (by seq. motif)               
      • Site search (by ligand complex)
    • LIGAND SITE MUTATIONS
    • Mutation coverage
    • Mutations
    • Mutation design tool
      • By receptor name
      • By PDB id
    • Mutation data submission
  • GproteinDb
    • Citing GproteinDb
    • G protein page
    • COUPLINGS
    • Couplings
    • Datasets
    • Biosensors
    • COUPLING ANALYSIS
    • Coupling selectivity (tree)
    • Coupling selectivity (Venn)
    • SEQUENCES
    • Sequence alignments
    • Generic residue number tables
    • STRUCTURES
    • Structure coverage
    • Structures
    • Structure models
    • STRUCTURE ANALYSIS
    • Interface interactions & profiling
    • Structure superposition
    • DETERMINANTS & MUTATIONS
    • Coupling determinant mutation design
    • Interface mutations & chimeras
  • ArrestinDb
    • Citing ArrestinDb
    • Arrestin page
    • COUPLINGS
    • Couplings
    • COUPLING ANALYSIS
    • Coupling selectivity (tree)
    • Coupling selectivity (Venn)
    • SEQUENCES
    • Sequence alignments
    • Generic residue number tables
    • STRUCTURES
    • Structure coverage
    • Structures
    • STRUCTURE ANALYSIS
    • Interface interactions (single structure)
    • DETERMINANTS & MUTATIONS
    • Interface mutations
  • Biased Signaling Atlas
    • Citing Biased Signaling Atlas
    • GUIDELINES
    • Community guidelines paper
    • Reference ligand selection
    • Template to calculate ligand bias factors
    • BIASED LIGANDS (for transducer family)
    • Biased ligand coverage
    • Biased ligands
    • Ligand bias rank orders
    • Ligand pathway profiles (Δlog(Emax/EC50))
    • Ligand pathway profiles (Δlog(Tau/KA))
    • BIASED LIGANDS (for transducer subtype)
    • Biased ligand coverage
    • Biased ligands
    • Ligand bias rank orders
    • Ligand pathway profiles (Δlog(Emax/EC50))
    • Ligand pathway profiles (Δlog(Tau/KA))
    • PATHWAY-PREFERRING LIGANDS (for transducer family)
    • Pathway-preferring ligand coverage
    • Pathway-preferring ligands (pathway ∆Log/(Emax/EC50)
    • Ligand pathway preference rank orders (Δlog(Emax/EC50))
    • Ligand pathway profiles (Log(Emax/EC50))
    • Pathways
    • Pathway effects
    • DATA DEPOSITION
    • Data submission
  • Join us
    • Data annotation
    • Database development
    • Scientific collaboration
    • Social media
    • Give feedback

Join us

Cite us

Main reference

  • -- select page --

      • Please cite the main reference and the reference for the page that you are using.

    • Target and compound information

      Disease indications and associations

      Expression (HPA)

      Targets Literature Novelty Structures All Drugs & Agents Stimulatory Inhibitory Tissue expression Overview Cancer expression
      Target ID Gene Protein Receptor family Ligand type Class Publications Novelty (Pharos) IDG target level Total Inactive Active Max Phase Drugs Agents Ligands Max Phase Drugs Agents Ligands Max Phase Drugs Agents Ligands
      Targets Diseases Compounds Disease associations
      Target ID Gene Protein Receptor family Ligand type Class Disease area
      (ICD11)      		 Disease
      (ICD11)      		 Indication area
      (ATC)      		 Indication
      (ATC)      		 Indication code
      (ATC)      		 Drugs Agents Score
      Targets Diseases Disease associations
      Target ID Gene Protein Receptor family Ligand type Class Disease area
      (ICD11)      		 Disease
      (ICD11)      		 Score